{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:44:32Z","timestamp":1791031472025,"version":"4.1.0"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,2,1]]},"abstract":"<jats:sec><jats:title>Background.<\/jats:title><jats:p>Candidal infections are an important cause of morbidity and mortality in the very low birth weight (VLBW) infant. Current intervention focuses on treatment once candidal septicemia is either suspected or diagnosed. Studies have suggested that colonization with candidal species is an important risk factor for subsequent infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective.<\/jats:title><jats:p>To determine whether prophylactic fluconazole for the first 28 days of life results in a decreased incidence of candidal colonization in the VLBW infant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Research Design.<\/jats:title><jats:p>Prospective, randomized, controlled, intention-to-treat design comparing prophylaxis with fluconazole versus placebo for the first 28 days of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting.<\/jats:title><jats:p>A tertiary level intensive care nursery in a major teaching hospital in Charleston, South Carolina.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients.<\/jats:title><jats:p>One hundred three infants with a birth weight of &amp;lt;1500 g, either inborn or outborn, who were admitted to the intensive care nursery between January 1998 and February 1999.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Infants were enrolled within 72 hours of life with rectal cultures performed on the day of randomization (DOR), as well as day of life (DOL) 7, 14, and 28. Those infants with a birth weight of &amp;lt;1250 g had additional cultures on DOL 35, 49, and 56. Cultures were plated on selective media for isolation of candidal organisms. Infants were randomized to receive either fluconazole (6 mg\/kg) or placebo on the DOR. Subsequent doses were given every 72 hours until DOL 7 and then every 24 hours until DOL 28. Medication was given either intravenously or by feeding tube once the infant had been gavage feeding for a 48-hour period without feeding intolerance. Aspartate aminotransferase and alanine aminotransferase levels were obtained on DOR and DOL 7, 14, and 28 to assess for fluconazole toxicity. The minimal inhibitory concentration to fluconazole was determined for all positive cultures to assess the development of resistance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>The infants who received fluconazole (n = 53) and placebo (n = 50) had no statistical difference in the major risk factors known to increase the chances of candidal septicemia in the VLBW infant. Rectal colonization by candidal species was detected in 8 of the 53 fluconazole-treated patients (15.1%) and in 23 of the 50 infants treated with placebo (46%). Fluconazole significantly reduced rectal colonization from DOL 14 through DOL 56 in all infants with a birth weight of &amp;lt;1250 g, and from DOL 14 through DOL 56 in all infants with a birth weight of 1250 to 1500 g. Alanine aminotransferase levels were higher in the fluconazole versus the placebo-treated group on DOL 14 (18.1 IU\/L vs 15 IU\/L), but no clinically significant abnormalities were observed. Candida albicans was the most common species isolated. There was no increase in species ofCandida noted for their intrinsic resistance to fluconazole, and there was no statistically significant difference in the minimal inhibitory concentrations to fluconazole for all C albicans isolates in either group at any period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Prophylactic administration of fluconazole to the VLBW infant for the first 28 days of life is safe and results in a decreased risk of rectal colonization by candidal species. Larger studies to determine the effect of prophylaxis on candidal septicemia and development of resistance in such a selective high-risk group are warranted before initiation of routine prophylaxis. fluconazole, very low birth weight infant, prophylaxis, candidal sepsis, sensitivities to fluconazole.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.107.2.293","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"293-298","source":"Crossref","is-referenced-by-count":206,"title":["Fluconazole for Prophylaxis Against Candidal Rectal Colonization in the Very Low Birth Weight Infant"],"prefix":"10.1542","volume":"107","author":[{"given":"Stephen D.","family":"Kicklighter","sequence":"first","affiliation":[{"name":"From Wake Medical Center, Raleigh, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley C.","family":"Springer","sequence":"additional","affiliation":[{"name":"Hennepin County Medical Center, Minnesota, Minneapolis, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Hulsey","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B.","family":"Turner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,2,1]]},"reference":[{"key":"2021121009490052800_B1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00006454-199807000-00004","article-title":"Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants.","volume":"17","author":"Fanaroff","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"2021121009490052800_B2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/00365549850160873","article-title":"Blood culture isolates during 6 years in a tertiary neonatal intensive care unit.","volume":"30","author":"Ronnestad","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"2021121009490052800_B3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1542\/peds.83.1.101","article-title":"Mucocutaneous and invasive candidiasis among very low birth weight (&lt;1500 grams) infants in intensive care nurseries: a prospective study.","volume":"83","author":"Faix","year":"1989","journal-title":"Pediatrics"},{"key":"2021121009490052800_B4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(96)70191-9","article-title":"Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development neonatal research network.","volume":"129","author":"Stoll","year":"1996","journal-title":"J Pediatr"},{"key":"2021121009490052800_B5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/514712","article-title":"Comparative study of mortality and morbidity in premature infants (birth weight &lt;1,250 g) with candidemia or candidal meningitis.","volume":"27","author":"Lee","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2021121009490052800_B6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00006454-198702000-00009","article-title":"Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study.","volume":"6","author":"Weese-Mayer","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"2021121009490052800_B7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1542\/peds.95.6.883","article-title":"Disseminated candidal infections and intravenous hydrocortisone in preterm infants.","volume":"95","author":"Botas","year":"1995","journal-title":"Pediatrics"},{"key":"2021121009490052800_B8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1172\/JCI106564","article-title":"Cyclic 3\u2032, 5\u2032-adenosine monophosphate in the human leukocyte: synthesis, degradation, and effects on neutrophil candidacidal activity.","volume":"50","author":"Bourne","year":"1971","journal-title":"J Clin Invest"},{"key":"2021121009490052800_B9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinids\/22.5.803","article-title":"Vertical and horizontal transmission of unique candida species to premature newborns.","volume":"22","author":"Waggoner-Fountain, LA, Walker MW, Hollis, RJ, et al","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2021121009490052800_B10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1542\/peds.78.2.225","article-title":"Fungal colonization in the very low birth weight infant.","volume":"78","author":"Baley","year":"1986","journal-title":"Pediatrics"},{"key":"2021121009490052800_B11","first-page":"520","article-title":"Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease.","volume":"13","author":"El-Mohandes","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"2021121009490052800_B12","first-page":"251","article-title":"Candidacolonization and infection in very low birth weight infants.","volume":"6","author":"Hageman","year":"1985","journal-title":"J Perinatol"},{"key":"2021121009490052800_B13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00006454-199809000-00014","article-title":"Association of fungal colonization and invasive disease in very low birth weight infants.","volume":"17","author":"Huang","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"2021121009490052800_B14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3476(05)81375-7","article-title":"Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates.","volume":"124","author":"Rowen","year":"1994","journal-title":"J Pediatr"},{"key":"2021121009490052800_B15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01974614","article-title":"A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies.","volume":"13","author":"Ninane","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021121009490052800_B16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.","volume":"326","author":"Goodman","year":"1992","journal-title":"N Eng J Med"},{"key":"2021121009490052800_B17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2007-999649","article-title":"Prophylactic oral nystatin and fungal infections in very-low-birthweight infants.","volume":"5","author":"Sims","year":"1988","journal-title":"Am J Perinatol"},{"key":"2021121009490052800_B18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00006454-199209000-00008","article-title":"Prophylactic miconazole oral gel for the prevention of neonatal fungal rectal colonization and systemic infection.","volume":"11","author":"Wainer","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"2021121009490052800_B19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00006454-199612000-00011","article-title":"Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial.","volume":"15","author":"Driessen","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"2021121009490052800_B20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/030006059702500408","article-title":"Fluconazole treatment of neonates and infants with severe fungal infections.","volume":"25","author":"Gurpinar","year":"1997","journal-title":"J Int Med Res"},{"key":"2021121009490052800_B21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00006454-199708000-00007","article-title":"Prospective study of fluconazole therapy in systemic neonatal fungal infection.","volume":"16","author":"Wainer","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"2021121009490052800_B22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00006454-199811000-00010","article-title":"Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis.","volume":"17","author":"Huttova","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"2021121009490052800_B23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/clpt.1993.147","article-title":"Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life.","volume":"54","author":"Saxen","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"2021121009490052800_B24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(95)00010-0","article-title":"The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.","volume":"100","author":"Nguyen","year":"1996","journal-title":"Am J Med"},{"key":"2021121009490052800_B25","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1128\/AAC.38.6.1422","article-title":"Fluconazole susceptibilities ofCandida species and distribution of species recovered from blood cultures over a 5-year period.","volume":"38","author":"Price","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"2021121009490052800_B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.39.1.1","article-title":"Resistance of Candidaspecies to fluconazole.","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2021121009490052800_B27"},{"key":"2021121009490052800_B28"},{"key":"2021121009490052800_B29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/j.1875-9114.1998.tb03114.x","article-title":"Update on clinical antifungal susceptibility testing for Candida species.","volume":"18","author":"Lewis","year":"1998","journal-title":"Pharmacotherapy"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/2\/293\/892206\/293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/2\/293\/892206\/293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T05:16:01Z","timestamp":1705209361000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/107\/2\/293\/66292\/Fluconazole-for-Prophylaxis-Against-Candidal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,1]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,2,1]]},"published-print":{"date-parts":[[2001,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.107.2.293","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2,1]]}}}